共 50 条
- [21] Substantial comorbidities and rising economic burden in real-world non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) patients with compensated cirrhosis (CC): A large German claims database studyJOURNAL OF HEPATOLOGY, 2018, 68 : S32 - S32Canbay, A.Meise, D.Haas, J. S.
- [22] Rising economic burden following the diagnosis of compensated cirrhosis among hospitalized patients with Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in SpainJOURNAL OF HEPATOLOGY, 2019, 70 (01) : E675 - E675Romero-Gomez, ManuelKachru, NanditaOzbay, Ahmet BurakDarba, Josep
- [23] Follow-Up Study of the Progression of Non-Alcoholic Steatohepatitis (NASH) in An Inducible Nitric Oxide Synthase (iNOS)-Knockout Mouse ModelGASTROENTEROLOGY, 2009, 136 (05) : A848 - A848Nozaki, YuchiFujita, KojiYoneda, MasatoWada, KoichiroShinohara, YoshiyasuMawatari, HironoriTakahashi, HirokazuInamori, MasahikoKobayashi, NoritoshiKirikoshi, HiroyukiKubota, KensukeSaito, SatoruNagashima, YojiNakajima, Atsushi
- [24] A mobile application for the management and follow-up of patients with Non-Alcoholic Fatty Liver DiseaseJOURNAL OF HEPATOLOGY, 2018, 68 : S819 - S819Forlano, R.Mullish, B. H.Katertsidis, N.Giannakeas, N.Tzallas, A.Tsipouras, M.Yee, M.Taylor-Robinson, S.Thursz, M.Manousou, P.
- [25] Inflammatory Cytokines Are Associated With Hepatic Steatosis and Fibrosis Measured by Computer-Assisted Morphometry (CAM) in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)GASTROENTEROLOGY, 2014, 146 (05) : S712 - S712Lam, Brian P.Estep, J. MichaelMonge, FannyAlaparthi, LakshmiGoodman, Zachary D.Fang, YunStepanova, MariaYounossi, Zobair M.
- [26] CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRYHEPATOLOGY, 2019, 70 : 749A - 750AYounossi, Zobair M.Yu, Ming-LungEl Kassas, MohamedEsmat, GamalYilmaz, YusufFernandez, Marlen CastellanosDuseja, Ajay K.Isakov, Vasily A.Buti, MariaMendez-Sanchez, NahumPapatheodoridis, George V.Chan, Wah KheongGeorge, JacobBugianesi, ElisabettaRomero-Gomez, ManuelRoberts, Stuart K.Younes, ZiadWong, Vincent Wai-SunFan, Jian-GaoEguchi, YuichiroGordon, Stuart C.Ahmed, AijazOng, JanusJacobson, Ira M.Rinella, Mary E.Hamid, Saeed S.Ziayee, MariamYounossi, IssahLam, Brian P.Arrese, MarcoNader, FatemaRacila, AndreiHenry, LindaStepanova, Maria
- [27] PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED CIRRHOSIS (CC): DATA FROM THE STELLAR-4 PHASE 3 CLINICAL TRIALHEPATOLOGY, 2019, 70 : 1119A - 1120AYounossi, Zobair M.Stepanova, MariaNader, FatemaRomero-Gomez, ManuelOkanoue, TakeshiTrauner, Michael H.Myers, Robert P.Djedjos, StephenHarrison, Stephen A.Goodman, Zachary D.
- [28] The Impact of Sleeve Gastrectomy Following Liver Transplant in Patients with Non-Alcoholic Steatosis: A Five-Year Experience.AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 414 - 414Morris, M. C.Jung, A. D.Kim, Y.Dhar, V. K.Shah, S.Schauer, D.Smith, E.Diwan, T.
- [29] Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up studyBMJ OPEN, 2022, 12 (06):Tang, XiaopingShi, YanyanDu, JuanHu, KemingZhou, TingtingChen, LanZhang, YanmingLi, FujunZhang, HuierLiebe, RomanMeyer, ChristophDooley, StevenZhu, ZhongweiWeng, Hong-LeiJia, JinzhuHuang, Tong
- [30] Statins in patients with elevated liver enzymes because of non-alcoholic fatty liver disease (NAFLD):: A clinical and histopathological follow-up studyJOURNAL OF HEPATOLOGY, 2006, 44 : S254 - S255Ekstedt, M.Franzen, L. E.Mathiesen, U. L.Bodemar, G.Kechagias, S.